BME100 f2016:Group4 W8AM L1

BME 100 Fall 2016	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Nathalie Nunez Name: Danielle Morelan Name: Manyta Parmar Name: Mark Mcpherson Name: Shannon Medovich Name: Your name LAB 1 WRITE-UP Health Care Issue Lyme Disease: In the U.S., Lyme Disease is the most common vector-borne illness. It is spread to humans by ticks, and the illness involves the body's response to the infection caused by Borrelia burgdorferi. N/A. "About Lyme Disease." LymeDisease.org. LymeDisease.org, n.d. Web. 1 Sept. 2016. <https://www.lymedisease.org/lyme-basics/lyme-disease/about-lyme/>. Competitors Western Blotting Advantages -Highly specific interaction between an antibody and an antigen -Detects proteins based on size and does not need to bind specifically to any 1 epitopes -Uses fluorescence Disadvantages -56% of tests are inaccurate (unexpected bands, no bands, misplaced bands) -Takes a long time -More difficult test -Costly “ELISA” (enzyme-linked immunosorbent assay) Advantages -High Sensitivity -Strong specificity -Cheap ($80-300) -No radioactivity Disadvantages -Antibodies are more difficult to find -Enzyme/substrate reaction is short term so micro-wells must be read quickly N/A. "Lyme Disease." Cdc.gov. Center for Disease Control and Prevention, n.d. Web. 1 Aug. 2016. <https://www.cdc.gov/lyme/>. N/A. "A Guide: The Diagnostic Dilemma of Lyme Disease."LymeResearchAlliance.org. Lyme Research Alliance, n.d. Web. 01 Sept. 2016. <http://www.lymeresearchalliance.org/test-diagnostic.html>. Customer Validation Patient Someone with Lyme's Disease Payer Health Insurance Physician Primary care physicians-Rheumatologist (Specialists) Provider Hospitals Purchaser Drug Research Companies IP Position Application Number/ Assignee_|________Title________|________Summary___________|___Filing date/ Status____ US10323204_______________|_Data processing and_|_It includes accessing_________|2002-12-18 -Active GE Medical Systems_________|feedback method and_|_image data for______________|_expires 2025-01-31 Global Technology Co LLC____|_system____________|_evaluation._________________| US09300971_______________| Peptides and assays__| Quick diagnosis using________| 1999-04-28 -Active Administrators of the Tulane___| for the diagnosis of____| proteins with specific________|expires 2019-04-28 Educational Fund___________| lyme disease_________| peptide and nucleic acid______| ______________________________________________| to sequence the proteins_____| Fundability Worksheet Scores Competitors 2-There are competitors, however, improvements are much needed because the tests to detect lyme disease are often inaccurate, expensive, or very time-consuming. Customer Validation 3-While there have not been any conversations with customers, it can be assumed that those who are in areas common with lyme disease would be very interested in this product so that they can avoid getting the illness. IP Position 3-There are patents in the detection of lyme disease.